title: Vascular endothelial growth factor pathway.
authors.affiliation: Department of Medicine, Section of Hematology/Oncology, University of Chicago, Maryland Avenue, Chicago, Illinois, USA.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Maitland
authors.forename: Xing Jian
authors.initials: XJ
authors.lastname: Lou
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Ramirez
authors.forename: Apurva A
authors.initials: AA
authors.lastname: Desai
authors.forename: Dorit S
authors.initials: DS
authors.lastname: Berlin
authors.forename: Howard L
authors.initials: HL
authors.lastname: McLeod
authors.forename: Ralph R
authors.initials: RR
authors.lastname: Weichselbaum
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Ratain
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology; D000068258:Bevacizumab; D002986:Clinical Trials as Topic; D015972:Gene Expression Regulation, Neoplastic; D005838:Genotype; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D010597:Pharmacogenetics; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab